BeyondSpring Inc. has announced promising results from a clinical study published in Med, showing that Plinabulin, when combined with radiation and PD-1 inhibitors, elicited a 23% overall response ...
Radiation therapy combined with Keytruda increased T cell infiltration in HR+ and HER2-negative breast cancer, enhancing immune response. High-dose radiation with Keytruda led to increased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results